Table 3 Implementation Results

1.1

It is documented that patient be advised of the audit process

2.1.1^a

Patients transferred to the practice for continuation of methadone treatment have a documented completed transfer summary/initial assessment

2.1.2^a

Patients who commence treatment in the practice have a documented initial assessment

2.1.3^a

Patients commencing treatment in the practice have a record of 3 drug screens confirming findings from assessment

2.1.4

1 of the 3 drug screens prior to commencing treatment is a 6 am test

2.1.5^a

Patients have been given information on methadone safety, risks and safe storage

3.1.1^a

All consultations with the GP are recorded

3.2.1^a

Patients have current dose of methadone recorded at each visit

3.2.2

The rationale for the dose of methadone if outside the therapeutic range is recorded

3.3.1^a

Patients have frequency of supervised dispensing recorded

3.3.2

Patients have rationale for supervised dispensing recorded

3.4.1

Is there a record of a minimum of one randomised drug screen per month?

3.4.2

All drug screens are positive for methadone/EDDP

3.5.1^a

There is a record if patients are using other substances along with their methadone

3.5.2^a

There is evidence of the interventions made if patients are using other substances along with their methadone (opiates, benzodiazepines, cocaine, alcohol, cannabis etc.)

3.6.1^a

All patients who are prescribed Benzodiazepines should have the rationale for prescribing recorded in their notes

3.6.2^a

All patients who are prescribed Benzodiazepines should have a review of the prescription in the past 3 months recorded in their notes

3.6.3^a

All patients who are prescribed Benzodiazepines should have the dose recorded in their notes

3.6.4^a

All patients who are prescribed Benzodiazepines should have evidence of 3 monthly reviews recorded in their notes

3.6.5^a

All patients who are prescribed Benzodiazepines should have evidence of communication with prescriber (if GP is not main prescriber) recorded in their notes

3.7.1^a

All patients who are prescribed Z-Hypnotics should have the rationale for prescribing recorded in their notes

3.7.2^a

All patients who are prescribed Z-Hypnotics should have a review of the prescription in the last 3 months recorded in their notes

3.7.3^a

All patients who are prescribed Z-Hypnotics should have the dose recorded in their notes

3.7.4^a

All patients who are prescribed Z-Hypnotics should have evidence of 3 monthly reviews recorded in their notes

3.7.5^a

All patients who are prescribed Z-Hypnotics should have evidence of communication with prescriber (if GP is not main prescriber) recorded in their notes

4.1.1^a

There is a record that patients at risk of blood borne viruses have been offered screening for HIV

4.1.2^a

There is a record that patients at risk of blood borne viruses have been offered screening for Hepatitis C

4.1.3^a

There is a record that patients at risk of blood borne viruses have been offered screening for Hepatitis B

4.1.4

There is a record that patients at risk of blood borne viruses have been offered screening for Hepatitis A

4.2.1^a

There is evidence that patients who are HIV positive have been referred to specialist service.

4.2.2^a

There is evidence that patients who are Hepatitis C antibody positive and PCR positive/ PCR testing not available have been referred to specialist service as appropriate.

4.3.1^a

There is evidence that patients who are Hep B negative have been offered vaccination.

4.3.2

All patients who have completed Hep B vaccination regime have been offered post vaccination Hep B antibody test

4.3.3

There is evidence that patients who are Hep A antibody negative have been offered Hep A vaccination